AU3176297A - Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof - Google Patents

Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof

Info

Publication number
AU3176297A
AU3176297A AU31762/97A AU3176297A AU3176297A AU 3176297 A AU3176297 A AU 3176297A AU 31762/97 A AU31762/97 A AU 31762/97A AU 3176297 A AU3176297 A AU 3176297A AU 3176297 A AU3176297 A AU 3176297A
Authority
AU
Australia
Prior art keywords
pyrimidines
pyrrolo
amino
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31762/97A
Inventor
Eva Altmann
Jurgen Klaus Maibaum
Martin Missbach
Leo Widler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Publication of AU3176297A publication Critical patent/AU3176297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU31762/97A 1996-06-25 1997-06-16 Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof Abandoned AU3176297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1591/96 1996-06-25
CH159196 1996-06-25
PCT/EP1997/003115 WO1997049706A1 (en) 1996-06-25 1997-06-16 SUBSTITUTED 7-AMINO-PYRROLO[3,2-d]PYRIMIDINES AND THE USE THEREOF

Publications (1)

Publication Number Publication Date
AU3176297A true AU3176297A (en) 1998-01-14

Family

ID=4214005

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31762/97A Abandoned AU3176297A (en) 1996-06-25 1997-06-16 Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof

Country Status (2)

Country Link
AU (1) AU3176297A (en)
WO (1) WO1997049706A1 (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL340412A1 (en) 1997-10-20 2001-01-29 Hoffmann La Roche Bicyclic kinase inhibitors
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
PA8474101A1 (en) 1998-06-19 2000-09-29 Pfizer Prod Inc PYROLEUM [2,3-D] PIRIMIDINE COMPOUNDS
KR100415791B1 (en) 1998-06-19 2004-01-24 화이자 프로덕츠 인코포레이티드 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
US6713474B2 (en) 1998-09-18 2004-03-30 Abbott Gmbh & Co. Kg Pyrrolopyrimidines as therapeutic agents
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
US7071199B1 (en) * 1999-09-17 2006-07-04 Abbott Gmbh & Cco. Kg Kinase inhibitors as therapeutic agents
WO2001042246A2 (en) 1999-12-10 2001-06-14 Pfizer Products Inc. PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
AU2000240570A1 (en) * 2000-03-29 2001-10-08 Knoll Gesellschaft Mit Beschraenkter Haftung Pyrrolopyrimidines as tyrosine kinase inhibitors
ATE423120T1 (en) 2000-06-26 2009-03-15 Pfizer Prod Inc PYRROLOÄ2,3-DÜPYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE ACTIVES
PT1301480E (en) * 2000-07-13 2007-11-29 Abbott Lab 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
US6515013B2 (en) 2000-07-13 2003-02-04 Abbott Laboratories 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
TWI238824B (en) 2001-05-14 2005-09-01 Novartis Ag 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives
US7301023B2 (en) 2001-05-31 2007-11-27 Pfizer Inc. Chiral salt resolution
JP2005502643A (en) 2001-08-10 2005-01-27 ノバルティス　アクチエンゲゼルシャフト Use of C-SRC inhibitors alone or in combination with STI571 for leukemia treatment
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
ES2201899B1 (en) * 2002-04-01 2005-06-01 Almirall Prodesfarma, S.A. DERIVATIVES OF AZAINDOLILPIPERIDINE AS ANTIHISTAMINIC AND ANTIALERGIC AGENTS.
AU2003246972A1 (en) 2002-08-06 2004-02-23 Astrazeneca Ab Condensed pyridines and pyrimidines with tie2 (tek) activity
EP1572213A1 (en) 2002-11-26 2005-09-14 Pfizer Products Inc. Method of treatment of transplant rejection
DK1599468T3 (en) 2003-01-14 2008-02-04 Arena Pharm Inc 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prevention and treatment of disorders associated therewith such as diabetes and hyperglycemia
EP2287166A3 (en) 2003-07-14 2011-06-22 Arena Pharmaceuticals, Inc. Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7557113B2 (en) 2003-08-26 2009-07-07 Teijin Pharma Limited Substituted pyrrolo[3,2-d]pyrimidine derivatives
EP1661897B1 (en) * 2003-08-26 2013-12-04 Teijin Pharma Limited Pyrrolopyrimidinone derivative
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
US20120101113A1 (en) 2007-03-28 2012-04-26 Pharmacyclics, Inc. Inhibitors of bruton's tyrosine kinase
MX2009010284A (en) * 2007-03-28 2010-01-29 Pharmacyclics Inc Inhibitors of bruton's tyrosine kinase.
UA103195C2 (en) 2008-08-11 2013-09-25 Глаксосмитклайн Ллк Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
RU2493157C2 (en) 2008-08-20 2013-09-20 Пфайзер Инк. PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES
BR112012005400A2 (en) 2009-09-10 2016-04-05 Irm Llc bicyclic heteroaryl ether type derivatives
KR101483215B1 (en) 2010-01-29 2015-01-16 한미약품 주식회사 Bicyclic heteroaryl derivatives having inhibitory activity for protein kinases
WO2011146313A1 (en) 2010-05-19 2011-11-24 The University Of North Carolina At Chapel Hill Pyrazolopyrimidine compounds for the treatment of cancer
IL300955A (en) 2010-06-03 2023-04-01 Pharmacyclics Llc (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin 1-yl)prop-2-en-1-one for use as a medicament for the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma
CN102947274A (en) 2010-06-17 2013-02-27 诺瓦提斯公司 Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
JP2013532149A (en) 2010-06-17 2013-08-15 ノバルティス アーゲー Piperidinyl-substituted 1,3-dihydro-benzimidazol-2-ylideneamine derivatives
SG188548A1 (en) 2010-09-22 2013-04-30 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012093809A2 (en) * 2011-01-03 2012-07-12 Hanmi Pharm Co., Ltd. New bicyclic compound for modulating g protein-coupled receptors
JP2014507465A (en) 2011-03-08 2014-03-27 ノバルティス アーゲー Fluorophenyl bicyclic heteroaryl compounds
AU2012225232B2 (en) 2011-03-09 2016-05-12 Richard G. Pestell Prostate cancer cell lines, gene signatures and uses thereof
JP5997252B2 (en) * 2011-04-04 2016-09-28 ファーマサイエンス・インコーポレイテッドＰｈａｒｍａｓｃｉｅｎｃｅ Ｉｎｃ． Protein kinase inhibitor
CA2760174A1 (en) * 2011-12-01 2013-06-01 Pharmascience Inc. Protein kinase inhibitors and uses thereof
KR20140048968A (en) 2011-07-13 2014-04-24 파마시클릭스, 인코포레이티드 Inhibitors of bruton's tyrosine kinase
PL2734186T3 (en) 2011-07-22 2019-01-31 Glaxosmithkline Llc Composition
CA2850617A1 (en) * 2011-10-03 2013-04-11 The University Of North Carolina At Chapel Hill Pyrrolopyrimidine compounds for the treatment of cancer
US8377946B1 (en) 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
CA2873743C (en) 2012-05-14 2022-12-06 Prostagene, Llc Using modulators of ccr5 for treating cancer
WO2013177168A1 (en) 2012-05-22 2013-11-28 The University Of North Carolina At Chapel Hill Pyrimidine compounds for the treatment of cancer
UA114421C2 (en) 2012-06-04 2017-06-12 Фармасайклікс Ллс Crystalline forms of a bruton's tyrosine kinase inhibitor
CN104704129A (en) 2012-07-24 2015-06-10 药品循环公司 Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (BTK)
SG11201500787YA (en) 2012-08-24 2015-03-30 Glaxosmithkline Llc Pyrazolopyrimidine compounds
WO2014062774A1 (en) 2012-10-17 2014-04-24 The University Of North Carolina At Chapel Hill Pyrazolopyrimidine compounds for the treatment of cancer
MX2015006168A (en) 2012-11-15 2015-08-10 Pharmacyclics Inc Pyrrolopyrimidine compounds as kinase inhibitors.
US9550785B2 (en) 2012-11-20 2017-01-24 Glaxosmithkline Llc Pyrrolopyrimidines as therapeutic agents for the treatment of diseases
ES2625023T3 (en) 2012-11-20 2017-07-18 Glaxosmithkline Llc Novel compounds
JP6228223B2 (en) * 2012-11-20 2017-11-08 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ New compounds
EP2925752A4 (en) 2012-11-27 2016-06-01 Univ North Carolina Pyrimidine compounds for the treatment of cancer
MA38961A1 (en) 2013-09-30 2018-05-31 Pharmacyclics Llc 3-phenyl-1h-pyrazolo [3,4-d] pyrimidin-4-ylamine compounds substituted for the crude tyrosine kinase inhibitors used to treat, for example, autoimmune, respiratory and inflammatory diseases, cancer, mastocytosis and osteoporosis
EP3057970A1 (en) * 2013-10-18 2016-08-24 Medivation Technologies, Inc. Heterocyclic compounds and methods of use
CA2833701A1 (en) * 2013-11-19 2015-05-19 Pharmascience Inc. Protein kinase inhibitors
WO2015143400A1 (en) 2014-03-20 2015-09-24 Pharmacyclics, Inc. Phospholipase c gamma 2 and resistance associated mutations
WO2015157125A1 (en) 2014-04-11 2015-10-15 The University Of North Carolina At Chapel Hill Therapuetic uses of selected pyrazolopyrimidine compounds with anti-mer tyrosine kinase activity
EP3194572B1 (en) 2014-07-30 2023-10-25 Yeda Research and Development Co. Ltd. Media for culturing pluripotent stem cells
BR112017002231A2 (en) 2014-08-07 2018-07-17 Pharmacyclics Llc new formulations of a bruton tyrosine kinase inhibitor
EP3242666A1 (en) 2015-01-06 2017-11-15 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor
SG11201707122QA (en) 2015-03-03 2017-09-28 Pharmacyclics Llc Pharmaceutical formulations of bruton's tyrosine kinase inhibtor
JP6838744B2 (en) 2015-06-22 2021-03-03 アリーナ ファーマシューティカルズ， インコーポレイテッド (R) -2- (7- (4-cyclopentyl-3- (trifluoromethyl) benzyloxy) -1,2,3,4-tetrahydrocyclopenta [b] indole-for use in S1P1 receptor-related disorders Crystalline L-arginine salt of 3-yl) acetic acid (Compound 1)
US10709708B2 (en) 2016-03-17 2020-07-14 The University Of North Carolina At Chapel Hill Method of treating cancer with a combination of MER tyrosine kinase inhibitor and an epidermal growth factor receptor (EGFR) inhibitor
EP3694866A1 (en) * 2017-10-13 2020-08-19 Imperial College Of Science, Technology And Medicine Map4k4 inhibitors
EP3730483B1 (en) 2017-12-21 2023-08-30 Hefei Institutes of Physical Science, Chinese Academy of Sciences Class of pyrimidine derivative kinase inhibitors
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
GB201819839D0 (en) * 2018-12-05 2019-01-23 Imperial Innovations Ltd MAP4K4 inhibitors
WO2020152686A1 (en) 2019-01-23 2020-07-30 Yeda Research And Development Co. Ltd. Culture media for pluripotent stem cells
WO2021097256A1 (en) 2019-11-14 2021-05-20 Cohbar, Inc. Cxcr4 antagonist peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010028A1 (en) * 1994-09-29 1996-04-04 Novartis Ag PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE
MX9709867A (en) * 1995-06-07 1998-03-31 Pfizer Heterocyclic ring-fused pyrimidine derivatives.

Also Published As

Publication number Publication date
WO1997049706A1 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
AU3176297A (en) Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof
AU1794697A (en) 7-alkyl-pyrrolo{2,3-d}pyrimidines
AU5752398A (en) Novel ketobenzamides and their use
AU4239896A (en) Dihydropyrimidines and uses thereof
AU3008297A (en) Dihydropyrimidines and uses thereof
EP1032377A4 (en) Substituted 2-aminoacetamides and the use thereof
AU1559897A (en) Bumper, and the fabrication thereof
AU2841697A (en) Sulfonamides and their use
AU2440997A (en) Calixpyrroles, calixpyridinopyrroles and calixpyridines
AU9284698A (en) Bumper, and the fabrication thereof
ZA964711B (en) Novel compounds, the preparation and use thereof.
AU1378500A (en) Novel pyrimidines, the production thereof and their use
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
AU1416195A (en) Substituted 1,2,3,4-tetrahydro-5-nitro pyrimidines
AU1441195A (en) Phenylmethyl hexanamides, and the use thereof
AU7495796A (en) Novel oligopeptides, the preparation and use thereof
HUP9600730A1 (en) 1,4-tetrazolinone-derivatives and use thereof as herbicides
AU6872896A (en) 4,4-difluoro-3-butenylester derivatives or 4,4-difluoro-3-halogen-3-butenylester derivatives and the use thereof as pesticides
AU5557698A (en) Novel calpaines, their preparation and use
AU8095598A (en) Hair-drier or the like
AU5646394A (en) Hinge arrangements, their construction and use
AU2766197A (en) Substituted phenyluracils and their use as herbicides
AU4619297A (en) Ptx sensitive g proteins, the production and use thereof
AU4506499A (en) Novel 2,4-diaminophenol derivatives and the use thereof
AU8736498A (en) Improvements in spectacles or the like